Filed with ASX · · 2 pages · English
Oncosil Medical Ltd has filed a Change of Director's Interest Notice, detailing changes in the interests of director Nigel Lange in the company's securities. The notice indicates that performance rights were lapsed without conversion, resulting in a decrease in the total number of performance rights held by the director. After the change, the director holds a specific number of shares, options, and performance rights.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced...
